Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032
... market trends in the United States, the EU-5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The Thrombocytopenia market report provides current treatment practices, emerging drugs, and market share of the individual therapies, ... Read More
-
North America Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
... America Biosimilars Market would witness market growth of 23.6% CAGR during the forecast period (2022-2028). Biosimilars are rigorously and thoroughly examined by the FDA before approval, and they are just as secure and efficient as ... Read More
-
Europe Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
... Market would witness market growth of 23.6% CAGR during the forecast period (2022-2028). The prevalence of autoimmune conditions like rheumatoid arthritis & ankylosing spondylitis is rising, fueling the growth of the biosimilars market. For the ... Read More
-
Global Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Regional Outlook and Forecast, 2022 - 2028
... Market size is expected to reach $59 billion by 2028, rising at a market growth of 24.4% CAGR during the forecast period. Biosimilar medicines are biotherapeutic products that are identical to an approved reference product ... Read More
-
Hemophilia Gene Therapy Market, by Hemophilia Type (Hemophilia A and Hemophilia B), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Hemophilia is a genetic bleeding disorder in which an individual lacks or has low levels of proteins called clotting factors. There are around 13 types of clotting factors that work with blood platelets, which are ... Read More
-
Hemostasis Products Market Size By Product (Topical Hemostasis Product {Gelatin, Polysaccharides , Oxidized Regenerated Cellulose, Collagen}), Infusible Hemostasis Products {Platelet Concentrate From Donor Blood, Fresh Frozen Plasma (FFP), Factor VIII, Prothrombin}), Advanced Hemostasis Products ({Flowable, Thrombin, Synthetic Sealants, Fibrin}), By Application (Trauma, Surgery, Hemophilia, Myocardial Infarction), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Thrombin, Synthetic Sealants, Fibrin}), By Application (Trauma, Surgery, Hemophilia, Myocardial Infarction), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030 The hemostasis products ... Read More
-
Hemoglobinopathies Market By Type (Thalassemia, Sickle Cell Disease, Others), By Therapy (Monoclonal Antibody Medication, ACE inhibitors, Hydroxyurea, Others), By Distribution Channel (Hospital Pharmacy, Online Providers, Drug Stores and Retail Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Forecast, 2021-2031 Hemoglobinopathy is a collective term used for the blood disorder that primarily affects the red blood cells (RBCs). The abnormal production or structural change in the hemoglobin molecule causes hemoglobinopathies. Majorly, hemoglobinopathies are ... Read More
-
Hemophilia- Pipeline Insight, 2022
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Hemophilia Understanding Hemophilia: Overview ... Read More
-
Hemophilia B (Factor IX Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... In Development, 2022, provides an overview of the Hemophilia B (Hematological Disorders) pipeline landscape. Hemophilia B is a hereditary bleeding disorder caused by a lack of blood clotting factor IX. Symptoms include bleeding into joints ... Read More
-
2022 Diseases of The Blood and Blood-Forming Organs and Certain Disorders Involving The Immune Mechanism (D50-D89) Global Market Size & Growth Report with COVID-19 Impact
... and Certain Disorders Involving The Immune Mechanism (D50-D89) Global Market Size & Growth Report covers market size, revenue, growth, and share across 4 global regions, 22 subregions, and 216 countries. Figures are from 2012 through ... Read More
-
Plasma Protein Therapeutics Market Report 2022-2032
... and Middle Income Countries Due to the worldwide initiatives, a rise in voluntary, unpaid blood donations from low- and middle-income countries has been noted to fulfil the unmet need for red blood cell concentrates. In ... Read More
-
Global POEMS Syndrome Market - 2022-2029
... of XX % during the forecast period (2022-2029). POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, Skin changes) syndrome is a blood disorder that affects several body systems. Abnormal plasma cells produce excessive quantities of antibody proteins ... Read More
-
Hemophilia Treatment Market By Type (Hemophilia A, Hemophilia B), By Drug Therapy (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... global hemophilia treatment market was valued at $12,764.8 million in 2021, and is projected to reach $26,905.2 million by 2031, registering a CAGR of 7.5% from 2022 to 2031. Hemophilia is usually an inherited bleeding ... Read More
-
Global Blood Plasma Fractionation Market Report, History and Forecast 2016-2027
... expected to reach US$ 44034 million by the end of 2027, with a CAGR of 7.63% between 2021 and 2027. Global Blood Plasma Fractionation Scope and Market Size The global Blood Plasma Fractionation market is ... Read More
-
Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Others); By Type; By End-Use; By Region; Segment Forecast, 2022 - 2030
... size is expected treach USD 56.92 Billion by 2030 according ta new study by Polaris Market Research. The report “Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von ... Read More
-
2022 Global Forecast for Anemia Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Chemotherapy Induced Anemia (Toxicology) pipeline landscape. Chemotherapy-induced anemia is a very common side effect of cancer treatment. Symptoms include severe fatigue, weakness, anxiety, lack of energy, shortness of ... Read More
-
Middle East and Turkey Hemophilia Treatment Market, by Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Desmopressin), by Disease Indication (Hemophilia A, Hemophilia B, and Hemophilia C), and b
... Egypt, Israel, Saudi Arabia, UAE, and Rest of Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hemophilia is rare disorder, in which in which the blood does not clot properly. In ... Read More
-
Hemophilia Treatment Market, by Product Type (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Antifibrinolytic Agents, and Desmopressin), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Onl
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hemophilia, a factor VIII deficiency, is a genetic disorder that is caused by the absence of the ... Read More
-
Lentiviral Vectors Market, By Product Type (1st-generation, 2nd-generation, and 3rd-generation), By Indication (HIV, β-thalassemia, X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy, and Wiskott-Aldrich Syndrome), By End User (Hospitals, Clinics
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Lentiviral vectors are potential gene transfer vehicles used in both research and gene therapy applications. Lentiviral vectors ... Read More
-
Hemophilia Gene Therapy Market - Size, Share, Trends, and Forecast, 2022 - 2028
... factors. Conventional treatment options include timely replacement of the specific clotting factor. Major pharma and biotech companies are conducting research and development to develop gene therapy for hemophilia due to various shortcomings with conventional therapy. ... Read More
-
The 2023-2028 World Outlook for Anemia Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Rare Hematology Plasma-Derived Factors
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Hemophilia Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Iron Deficiency Anemia Drugs
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
Research Assistance
